5'-methylthioadenosine has been researched along with thioguanine anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, S; Luo, JJ | 1 |
| Anderson, S; Bell, RH; Beltran, H; Bertino, JR; Brahmbhatt, S; Cheng, H; Chinnaiyan, AM; Collins, CC; Demichelis, F; Fazli, L; Gleave, M; Gout, PW; Haegert, A; Hirst, M; Hurtado-Coll, A; Lapuk, AV; Lubin, M; Maher, CA; Marra, M; Rubin, MA; Volik, SV; Wang, Y; Wu, C; Xue, H | 1 |
2 other study(ies) available for 5'-methylthioadenosine and thioguanine anhydrous
| Article | Year |
|---|---|
Chick sympathetic neurons in culture respond differentially to nerve growth factor and conditioned medium from activated splenic lymphocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine; Animals; Cell Survival; Cells, Cultured; Chickens; Culture Media; Deoxyadenosines; Ganglia, Sympathetic; Isoquinolines; Kinetics; Lymphocyte Activation; Lymphocytes; Nerve Growth Factors; Neurons; Piperazines; Proadifen; Protein Kinase Inhibitors; Spleen; Thioguanine; Thionucleosides | 1991 |
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p16; Deoxyadenosines; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neuroendocrine Tumors; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Sequence Analysis, DNA; Thioguanine; Thionucleosides; Treatment Outcome; Urethral Neoplasms; Xenograft Model Antitumor Assays | 2012 |